You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 8, August 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Skin Cancer in Patients With Psoriasis Treated With Coal Tar

A 25-Year Follow-up Study

Mark R. Pittelkow, MD; Harold O. Perry, MD; Sigfrid A. Muller, MD; Willard Z. Maughan, MD; Peter C. O'Brien, PhD

Arch Dermatol. 1981;117(8):465-468.


Abstract

• For many years, crude coal tar has been used for the treatment of psoriasis. The possible carcinogenic effect of crude coal tar and ultraviolet (UV) radiation (Goeckerman regimen), considered individually or in combination, has been of some concern to physicians. A 25-year follow-up study was completed on 280 patients with psoriasis who were hospitalized and treated with crude coal tar and UV radiation at the Mayo Clinic, Rochester, Minn, during the years 1950 through 1954. The results of this study suggest that the incidence of skin cancer is not appreciably increased above the expected incidence for the general population when patients are treated with coal tar ointments. It seems that the Goeckerman regimen (topical crude coal tar combined with UV radiation) can be used with minimal risk for skin cancer in the treatment of psoriasis.

(Arch Dermatol 1981;117:465-468)



Author Affiliations

From the Department of Dermatology and the Section of Medical Research Statistics, Mayo Clinic and Mayo Foundation, Rochester, Minn.


Footnotes

Accepted for publication Nov 17, 1980.

Reprint requests to Section of Publications, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (Dr Pittelkow).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Final Safety Assessment of Coal Tar as Used in Cosmetics
International Journal of Toxicology 2008;27:1-24.
ABSTRACT | FULL TEXT  

Psoriasis treatment: traditional therapy
Lebwohl et al.
Ann Rheum Dis 2005;64:ii83-ii86.
ABSTRACT | FULL TEXT  

Treatment With UV-B for Psoriasis and Nonmelanoma Skin Cancer: A Systematic Review of the Literature
Pasker-de Jong et al.
Arch Dermatol 1999;135:834-840.
ABSTRACT | FULL TEXT  

HPLC/fluorescence determination of anti-BPDE–DNA adducts in mononuclear white blood cells from PAH-exposed humans
Pavanello et al.
Carcinogenesis 1999;20:431-435.
ABSTRACT | FULL TEXT  

Human Papillomavirus and Widespread Cutaneous Carcinoma After PUVA Photochemotherapy
Weinstock et al.
Arch Dermatol 1995;131:701-704.
ABSTRACT  

Treatment of Psoriasis
Greaves and Weinstein
NEJM 1995;332:581-589.
FULL TEXT  

The Treatment of Severe Psoriasis: A National Survey
Peckham et al.
Arch Dermatol 1987;123:1303-1307.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.